Gera Neufeld
#144,570
Most Influential Person Now
Researcher
Gera Neufeld's AcademicInfluence.com Rankings
Gera Neufeldcomputer-science Degrees
Computer Science
#7163
World Rank
#7543
Historical Rank
Machine Learning
#2561
World Rank
#2595
Historical Rank
Artificial Intelligence
#2852
World Rank
#2896
Historical Rank
Database
#4222
World Rank
#4392
Historical Rank
Download Badge
Computer Science
Why Is Gera Neufeld Influential?
(Suggest an Edit or Addition)Gera Neufeld's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Vascular endothelial growth factor (VEGF) and its receptors (1999) (3590)
- Neuropilin-1 Is Expressed by Endothelial and Tumor Cells as an Isoform-Specific Receptor for Vascular Endothelial Growth Factor (1998) (2519)
- Structural characterization and biological functions of fibroblast growth factor. (1987) (1256)
- Interleukin 6 Induces the Expression of Vascular Endothelial Growth Factor (*) (1996) (1053)
- Capillary endothelial cells express basic fibroblast growth factor, a mitogen that promotes their own growth (1987) (763)
- Allosteric inhibition of lysyl oxidase–like-2 impedes the development of a pathologic microenvironment (2010) (734)
- Fibroblast growth factor (1986) (680)
- Patterns of expression of vascular endothelial growth factor (VEGF) and VEGF receptors in mice suggest a role in hormonally regulated angiogenesis. (1993) (570)
- VEGF145, a Secreted Vascular Endothelial Growth Factor Isoform That Binds to Extracellular Matrix* (1997) (555)
- A unique signal transduction from FLT tyrosine kinase, a receptor for vascular endothelial growth factor VEGF. (1995) (515)
- The binding of vascular endothelial growth factor to its receptors is dependent on cell surface-associated heparin-like molecules. (1992) (488)
- Molecular and biological characterization of fibroblast growth factor, an angiogenic factor which also controls the proliferation and differentiation of mesoderm and neuroectoderm derived cells. (1986) (461)
- Enhancing the vascularization of three-dimensional porous alginate scaffolds by incorporating controlled release basic fibroblast growth factor microspheres. (2003) (427)
- The semaphorins: versatile regulators of tumour progression and tumour angiogenesis (2008) (395)
- The neuropilins: multifunctional semaphorin and VEGF receptors that modulate axon guidance and angiogenesis. (2002) (368)
- Neuropilin-1 Is a Placenta Growth Factor-2 Receptor* (1998) (366)
- Characterization of Novel Vascular Endothelial Growth Factor (VEGF) Receptors on Tumor Cells That Bind VEGF via Its Exon 7-encoded Domain (*) (1996) (352)
- Neuropilin-2 and Neuropilin-1 Are Receptors for the 165-Amino Acid Form of Vascular Endothelial Growth Factor (VEGF) and of Placenta Growth Factor-2, but Only Neuropilin-2 Functions as a Receptor for the 145-Amino Acid Form of VEGF* (2000) (344)
- Fibroblast growth factor: Structural and biological properties (1987) (330)
- The identification and partial characterization of the fibroblast growth factor receptor of baby hamster kidney cells. (1985) (317)
- Basic and acidic fibroblast growth factors interact with the same cell surface receptors. (1986) (311)
- Functional interaction of VEGF‐C and VEGF‐D with neuropilin receptors (2006) (307)
- Characterization of the receptors for vascular endothelial growth factor. (1990) (304)
- Neuropilin-2 interacts with VEGFR-2 and VEGFR-3 and promotes human endothelial cell survival and migration. (2006) (296)
- Differential expression of neuropilin-1 and neuropilin-2 in arteries and veins (2001) (284)
- VEGF121, a vascular endothelial growth factor (VEGF) isoform lacking heparin binding ability, requires cell-surface heparan sulfates for efficient binding to the VEGF receptors of human melanoma cells (1995) (275)
- NEUROPILIN-2 AND NEUROPILIN-1 ARE RECEPTORS FOR VEGF165 AND PLGF-2, BUT ONLY NEUROPILIN-2 FUNCTIONS AS A RECEPTOR FOR VEGF145 . (2000) (267)
- A new communication system between hepatocytes and sinusoidal endothelial cells in liver through vascular endothelial growth factor and Flt tyrosine kinase receptor family (Flt-1 and KDR/Flk-1). (1994) (266)
- Neuropilin-2 is a receptor for the vascular endothelial growth factor (VEGF) forms VEGF-145 and VEGF-165 [corrected]. (2000) (245)
- Semaphorin-3F Is an Inhibitor of Tumor Angiogenesis (2004) (232)
- Semaphorin-3A and Semaphorin-3F Work Together to Repel Endothelial Cells and to Inhibit Their Survival by Induction of Apoptosis* (2007) (221)
- Platelet Factor-4 Inhibits the Mitogenic Activity of VEGF121 and VEGF165 Using Several Concurrent Mechanisms (*) (1995) (214)
- Lysyl oxidase-related protein-1 promotes tumor fibrosis and tumor progression in vivo. (2003) (204)
- Pituitary follicular cells produce basic fibroblast growth factor. (1987) (199)
- Heparin modulates the interaction of VEGF165 with soluble and cell associated flk-1 receptors. (1994) (195)
- Basic fibroblast growth factor is synthesized in cultured retinal pigment epithelial cells. (1987) (191)
- Glypican-1 Is a VEGF165 Binding Proteoglycan That Acts as an Extracellular Chaperone for VEGF165 * (1999) (189)
- The interaction of Neuropilin-1 and Neuropilin-2 with tyrosine-kinase receptors for VEGF. (2002) (184)
- Bovine granulosa cells produce basic fibroblast growth factor. (1987) (181)
- Selective Binding of VEGF to One of the Three Vascular Endothelial Growth Factor Receptors of Vascular Endothelial Cells (*) (1996) (180)
- Abnormal deposition of collagen around hepatocytes in Wilson's disease is associated with hepatocyte specific expression of lysyl oxidase and lysyl oxidase like protein-2. (2005) (176)
- Vascular Endothelial Growth Factor Receptor-1 and Neuropilin-2 Form Complexes* (2001) (170)
- Human melanoma cells but not normal melanocytes express vascular endothelial growth factor receptors. (1993) (156)
- The neuropilins and their role in tumorigenesis and tumor progression. (2006) (154)
- Heparin modulation of the neurotropic effects of acidic and basic fibroblast growth factors and nerve growth factor on PC12 cells (1987) (152)
- Successful Inhibition of Tumor Development by Specific Class-3 Semaphorins Is Associated with Expression of Appropriate Semaphorin Receptors by Tumor Cells (2008) (144)
- Basic fibroblast growth factor in human rhabdomyosarcoma cells: implications for the proliferation and neovascularization of myoblast-derived tumors. (1987) (142)
- Neuropilin-1-VEGFR-2 Complexing Requires the PDZ-binding Domain of Neuropilin-1* (2008) (140)
- Vascular endothelial growth factor and its receptors. (1994) (133)
- Similarities and differences between the vascular endothelial growth factor (VEGF) splice variants (1996) (129)
- Semaphorins in cancer. (2005) (127)
- Expression of human basic fibroblast growth factor cDNA in baby hamster kidney-derived cells results in autonomous cell growth (1988) (127)
- Semaphorin-3B is an angiogenesis inhibitor that is inactivated by furin-like pro-protein convertases. (2008) (126)
- Expression of basic fibroblast growth factor in the nervous system of early avian embryos. (1990) (122)
- Plexin-A4 promotes tumor progression and tumor angiogenesis by enhancement of VEGF and bFGF signaling. (2011) (122)
- Vascular endothelial growth factor is inactivated by binding to alpha 2-macroglobulin and the binding is inhibited by heparin. (1993) (121)
- The chemorepulsive axon guidance protein semaphorin3A is a constituent of perineuronal nets in the adult rodent brain (2013) (119)
- Semaphorins in angiogenesis and tumor progression. (2012) (116)
- Oncogenic transformation induces tumor angiogenesis: a role for PAR1 activation (2003) (114)
- Variations in the size and sulfation of heparin modulate the effect of heparin on the binding of VEGF165 to its receptors. (1994) (110)
- Basic fibroblast growth factor: expression in cultured bovine vascular smooth muscle cells. (1988) (110)
- Thrombin-induced release of active basic fibroblast growth factor-heparan sulfate complexes from subendothelial extracellular matrix. (1993) (109)
- Aberrant Expression of Neuropilin-1 and -2 in Human Pancreatic Cancer Cells (2004) (96)
- Basic fibroblast growth factor accumulates in the nuclei of various bFGF‐producing cell types (1990) (96)
- The murine flg gene encodes a receptor for fibroblast growth factor. (1990) (94)
- Tumour growth inhibition and anti-metastatic activity of a mutated furin-resistant Semaphorin 3E isoform (2012) (92)
- Effect of vascular endothelial growth factor on hepatic regenerative activity following partial hepatectomy in rats. (1999) (91)
- Neuropilin-1-dependent regulation of EGF-receptor signaling. (2012) (91)
- Fibroblast growth factor receptor 4 is a high affinity receptor for both acidic and basic fibroblast growth factor but not for keratinocyte growth factor. (1993) (86)
- Protamine sulfate inhibits mitogenic activities of the extracellular matrix and fibroblast growth factor, but potentiates that of epidermal growth factor (1987) (85)
- Basic fibroblast growth factor: expression in cultured cells derived from corneal endothelium and lens epithelium. (1988) (84)
- Pro-angiogenic cytokines and their role in tumor angiogenesis (2006) (84)
- Neuropilin‐1 and neuropilin‐2 enhance VEGF121 stimulated signal transduction by the VEGFR‐2 receptor (2007) (83)
- The VEGF Splice Variants: Properties, Receptors, and Usage for the Treatment of Ischemic Diseases (2000) (82)
- The role of the semaphorins in cancer (2016) (82)
- A novel asymmetric 3D in-vitro assay for the study of tumor cell invasion (2009) (73)
- VEGF162, A New Heparin-binding Vascular Endothelial Growth Factor Splice Form That Is Expressed in Transformed Human Cells* (2003) (73)
- Full-Length Semaphorin-3C Is an Inhibitor of Tumor Lymphangiogenesis and Metastasis. (2015) (71)
- Selective binding of VEGF121 to one of the three vascular endothelial growth factor receptors of vascular endothelial cells. (1996) (71)
- Basic fibroblast growth factor: production and growth stimulation in cultured adrenal cortex cells. (1987) (69)
- Basic fibroblast growth factor as a growth inhibitor for cultured human tumor cells. (1987) (69)
- Semaphorin-3D and Semaphorin-3E Inhibit the Development of Tumors from Glioblastoma Cells Implanted in the Cortex of the Brain (2012) (67)
- Identification of the fibroblast growth factor receptor in human vascular endothelial cells (1988) (67)
- Segregation of arterial and venous markers in subpopulations of blood islands before vessel formation (2005) (66)
- Neuropilin‐2 is a novel marker expressed in pancreatic islet cells and endocrine pancreatic tumours (2002) (64)
- Lysyl oxidase-like-2 promotes tumour angiogenesis and is a potential therapeutic target in angiogenic tumours. (2013) (64)
- In vitro neutralization of vascular endothelial growth factor activation of Flk-1 by a monoclonal antibody (1994) (62)
- Glycosylation of vascular endothelial growth factor is not required for its mitogenic activity. (1992) (62)
- Semaphorin 3A is a marker for disease activity and a potential immunoregulator in systemic lupus erythematosus (2012) (62)
- The expression of lysyl‐oxidase gene family members in myeloproliferative neoplasms (2013) (58)
- Integration of Repulsive Guidance Cues Generates Avascular Zones That Shape Mammalian Blood Vessels (2012) (55)
- PCR-based identification of new receptors: molecular cloning of a receptor for fibroblast growth factors. (1991) (53)
- Class-3 Semaphorins and Their Receptors: Potent Multifunctional Modulators of Tumor Progression (2019) (52)
- The semaphorins and their receptors as modulators of tumor progression. (2016) (50)
- High levels of biologically active vascular endothelial growth factor (VEGF) are produced by the baculovirus expression system. (1992) (50)
- Dormant tumor cells expressing LOXL2 acquire a stem-like phenotype mediating their transition to proliferative growth (2016) (48)
- The Enzymatic Activity of Lysyl Oxidas-like-2 (LOXL2) Is Not Required for LOXL2-induced Inhibition of Keratinocyte Differentiation* (2011) (46)
- Receptor activity modifying protein‐3 mediates the protumorigenic activity of lysyl oxidase‐like protein‐2 (2011) (46)
- Semaphorin signaling in vascular and tumor biology. (2007) (45)
- Growth Factors, Receptor Kinases, and Protein Tyro sine Phosphatases in Normal and Malignant Melanocytes (1992) (44)
- Release of cell surface‐associated basic fibroblast growth factor by glycosylphosphatidylinositol‐specific phospholipase C (1992) (41)
- Neuroendocrine cells along the digestive tract express neuropilin-2. (2001) (39)
- Localized LoxL3-Dependent Fibronectin Oxidation Regulates Myofiber Stretch and Integrin-Mediated Adhesion. (2016) (37)
- Modeling invasive breast cancer: growth factors propel progression of HER2-positive premalignant lesions (2012) (37)
- Fibroblast growth factor. (1986) (33)
- The role of the plexin-A2 receptor in Sema3A and Sema3B signal transduction (2014) (33)
- The contribution of proangiogenic factors to the progression of malignant disease: role of vascular endothelial growth factor and its receptors. (2001) (31)
- Basic fibroblast growth factor is present in cultured human retinoblastoma cells. (1987) (30)
- Functional implantation of a solubilized beta-adrenergic receptor in the membrane of a cell. (1980) (30)
- Heparanase 2 Attenuates Head and Neck Tumor Vascularity and Growth. (2016) (30)
- LOXL2 upregulates phosphorylation of ezrin to promote cytoskeletal reorganization and tumor cell invasion. (2019) (30)
- BHK-21-derived cell lines that produce basic fibroblast growth factor, but not parental BHK-21 cells, initiate neuronal differentiation of neural crest progenitors. (1992) (29)
- A three‐gene signature from protein–protein interaction network of LOXL2‐ and actin‐related proteins for esophageal squamous cell carcinoma prognosis (2017) (26)
- Effect of lipoproteins and growth factors on the proliferation of BHK-21 cells in serum free culture (1986) (26)
- Sema-3A indirectly disrupts the regeneration process of goldfish optic nerve after controlled injury (2010) (23)
- Basic fibroblast growth factor is hepatotropic for rat liver in regeneration. (1995) (22)
- Electron spin resonance microscopic imaging of oxygen concentration in cancer spheroids. (2015) (20)
- Semaphorin 3A Is Effective in Reducing Both Inflammation and Angiogenesis in a Mouse Model of Bronchial Asthma (2019) (20)
- hVEGF165 Increases Survival of Transplanted Hepatocytes Within Portal Radicles: Suggested Mechanism for Early Cell Engraftment (2005) (20)
- Increased Vascular Endothelial Growth Factor 165 Binding to Kinase Insert Domain-Containing Receptor After Infection of Human Endothelial Cells by Recombinant Adenovirus Encoding the Vegf165 Gene (2001) (17)
- Complexes of plexin-A4 and plexin-D1 convey semaphorin-3C signals to induce cytoskeletal collapse in the absence of neuropilins (2018) (17)
- Trapping of the beta-adrenergic receptor in the hormone-induced state. (1983) (14)
- Hybridization of adenylate cyclase components by membrane fusion and the effect of selective digestion by trypsin. (1980) (14)
- Semaphorin-3A inhibits multiple myeloma progression in a mouse model (2018) (14)
- Semaphorin3A: A Potential Therapeutic Tool for Lupus Nephritis (2018) (13)
- Activation of a transfected FGFR‐1 receptor in Madin‐Darby epithelial cells results in a reversible loss of epithelial properties (1995) (12)
- The Neuropilins: Role and Function in Health and Disease (2017) (8)
- Fibroblast Growth Factor: Molecular and Biological Properties (1987) (8)
- Lysyl Oxidase Family Enzymes and Their Role in Tumor Progression (2022) (7)
- A Sema3C Mutant Resistant to Cleavage by Furin (FR-Sema3C) Inhibits Choroidal Neovascularization (2016) (7)
- Heparanase 2 (Hpa2) attenuates tumor growth by inducing Sox2 expression. (2021) (7)
- Overexpression of basic fibroblast growth factor complementary DNA in Ha-ras-transformed cells correlates with a decreased incidence of tumor necrosis. (1993) (6)
- A SEMA3E mutant resistant to cleavage by furins (UNCL-SEMA3E) inhibits choroidal neovascularization. (2016) (5)
- The Molecular Mechanism of Action of the β-Adrenergic Receptor (1983) (5)
- Gene expression pattern Differential expression of neuropilin-1 and neuropilin-2 in arteries and veins (2001) (4)
- VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1 (VEGFR-1) AND NEUROPILIN-2 FORM COMPLEXES (2001) (4)
- The molecular mechanism of action of the beta-adrenergic receptor. (1983) (2)
- Semaphorins, Plexins and Neuropilins and Their Role in Vasculogenesis and Angiogenesis (2007) (2)
- Chapter 17 – An Asymmetric 3D In Vitro Assay for the Study of Tumor Cell Invasion (2012) (2)
- Regulation of Angiogenesis and Tumor Progression by Semaphorins (2015) (1)
- Knock-Out of the Five Lysyl-Oxidase Family Genes Enables Identification of Lysyl-Oxidase Pro-Enzyme Regulated Genes (2022) (1)
- CD72-semaphorin3A axis: A new regulatory pathway in systemic lupus erythematosus. (2022) (1)
- Reconstitution of partial reactions requiring the beta-adrenergic receptor and the specific response to binding of the agonist. (1984) (1)
- Response to “Binding of the C‐terminal amino acids of VEGF121 directly with neuropilin‐1 should be considered” (2007) (1)
- Effects of class-3 semaphorins on brain tumour progression (2011) (0)
- Compositions and methods for treating tumors, and pulmonary alveolar proteinosis fibrosis (2008) (0)
- Truncated-semaphorin3A is a potential regulatory molecule to restore immune homeostasis in immune-mediated diseases (2023) (0)
- Early effects and expression of basic fibroblast growth factor (bFGf) in the developing avian nervous system (1989) (0)
- [Pulmonary changes in poisonings with organophosphoric substances in children]. (1980) (0)
- Plexin-A2 Promotes The Proliferation And The Development Of Tumors From Glioblastoma Derived Cells (2021) (0)
- Ocular versus Extraocular Neovascularization : Mirror Images or Vague Resemblances (2006) (0)
- Basic fibroblast growth factor (bFGF) is present in nuclei of various bFGF producing cell types (1990) (0)
- W1981 Lysyl Oxidase Like Protein 2 (Loxl2) and Loxl3 Expression Is Up-Regulated in Colorectal Carcinoma (2008) (0)
- Semaphorin-3C Resistant To Cleavage By Furins Inhibits Choroidal Neovascularization (2016) (0)
- VEGF deprivation-induced apoptosis is an essential component of programmed capillary regression (1999) (0)
- Reconstitution of the primary action of a hormone receptor using solubilized components. (1981) (0)
- High prevalence of chronic gastrointestinal symptoms in Holocaust survivors (2003) (0)
- Modulation of tumor growth, angiogenesis and metastatic capacity by heparin-like molecules (1993) (0)
- Uses of angiogenic factor vegf145 in the treatment of cardiovascular diseases (1997) (0)
- Abstract 3268: Targeting Semaphorin signaling to inhibit tumor growth and metastatic spreading (2011) (0)
- pharmaceutical compositions and methods useful for modulating angiogenesis, inhibit metastasis and tumor fibrosis, and evaluate malignancy of cancerous colon tumors (2003) (0)
- LOXL2-dependent deacetylation of aldolase A induces metabolic reprogramming and tumor progression (2022) (0)
- Basic fibroblast growth factor in human rhabdomyosarcoma cells : Implications for the proliferation and neovascularization of myoblast-derived tumors ( fibroblast growth factor gene expression / fibroblast growth factor receptor / heparin binding / angiogenesis ) (0)
- [Effects of magnesium therapy in a case vitamin D resistant rickets of the De Toni-Debré-Fanconi type]. (1974) (0)
- Some Problems of Trial Design for Anti-Angiogenic Agents in Cancer Therapy (1994) (0)
- Pulmonary alterations in intoxications with organo phosphoric substances in children (1980) (0)
- Introduction and Brief Historical Overview (2017) (0)
- LENGTH SEMAPHORIN-3 C IS AN INHIBITOR OF TUMOR LYMPHANGIOGENESIS AND METASTASIS By : (2015) (0)
- The Role of the Neuropilins and Their Associated Plexin Receptors in Tumor Angiogenesis and Tumor Progression (2008) (0)
- Trapping of the fi-adrenergic receptor in the hormone-induced state ( receptor response / receptor locking / detergent effect on receptor / receptor-induced fit / agonist-antagonist difference ) (0)
- Plexin-A2 enables the proliferation and the development of tumors from glioblastoma derived cells (2023) (0)
- Neuropilin-2 interacts with VEGFR-2 and VEGFR-3 and promotes human endothelial cells survival and migration Running title: Neuropilin-2 enhances VEGFR-2 cellular responses (2006) (0)
- The Characterization of Fibroblast Growth Factor and its Biological Effect in Vitro and in Vivo (1989) (0)
- Functional implantation of a solubilized 3-adrenergic receptor in the (2016) (0)
- Abstract 4594: Cytoplasmic LOXL2 regulates actin cytoskeletal organization in esophageal squamous cell carcinoma progression (2019) (0)
- Compositions and methods for treatment of pulmonary alveolar proteinosis the (2008) (0)
- Pharmaceutical compositions and methods useful for the modulation of angiogenesis, inhibition of metastasis and tumor fibrosis, and evaluate malignancy of coloncancertumorer (2003) (0)
- ' s response to reviews Title : A novel asymmetric 3 D in-vitro assay for the study of tumor cell invasion (2009) (0)
- Compositions and uses for the treatment of pulmonary alveolar proteinosis (2008) (0)
- The effect of basic-fibroblat growth factor, (bFGF) on liver regeneration after partial hepatectomy (1991) (0)
- Abstracts from Rambam Research Day, December 11, 2014 (2015) (0)
- CHAPTER 10 Semaphorin Signaling in Vascular and Tumor Biology (0)
- VEGF effect on hepatocyte engraftment after intrasplenic cell transplantation in rats (2002) (0)
- A SEMA3E MUTANT RESISTANT TO CLEAVAGE BY FURINS (UNCL-SEMA3E) INHIBITS LASER INDUCED CHOROIDAL NEOVASCULARIZATION (2015) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Gera Neufeld?
Gera Neufeld is affiliated with the following schools:
